Phospholipid Encapsulation of an Anti-Fibrotic Endopeptide to Enhance Cellular Uptake and Myocardial Retention

• Published in: Cells (Basel, Switzerland) Switzerland), 2023-06, Vol.12 (12), p.1589
• Main Authors: Sonkawade, Swati D, Xu, Shirley, Kim, Minhyung, Nepali, Sarmila, Karambizi, Victoire-Grace, Sexton, Sandra, Turowski, Steven G, Li, Kunpeng, Spernyak, Joseph A, Lovell, Jonathan F, George, Anthony, Suwal, Sujit, Sharma, Umesh C, Pokharel, Saraswati
• Format: Article
• Language: English
• Subjects: Animal models; Animals; Bioavailability; Blood pressure; C57BL/6j; cardiac fibroblasts; Cardiac function; Care and treatment; Cell membranes; Cholesterol; Chromatography; Clinical trials; Collagen - metabolism; Computed tomography; Coronary artery; Efficiency; Encapsulation; Enzymes; Fibroblasts; Fibrosis; Flow cytometry; Fluorescence microscopy; Heart; Heart failure; Hemodialysis; Humans; Inflammation; Ischemia; Light scattering; Lipid bilayers; Lipids; liposome; Liposomes; Liposomes - metabolism; Macrophages; Mammals - metabolism; Mice; Microscopy; Myocardial infarction; Myocardial Infarction - metabolism; Myocardium; Myocardium - metabolism; Peptides; Phosphocholine; Phospholipids; Phospholipids - metabolism; Physiological aspects; Pulmonary fibrosis; RAW 264.7 macrophages; Scanning electron microscopy; Tissue Distribution; Transforming growth factor-b1
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12121589

Cardioprotective effects of -acetyl-ser-asp-lys-pro (Ac-SDKP) have been reported in preclinical models of myocardial remodeling. However, the rapid degradation of this endogenous peptide in vivo limits its clinical use. To prolong its bioavailability, Ac-SDKP was encapsulated by phosphocholine lipid bilayers (liposomes) similar to mammalian cell membranes. The physical properties of the liposome structures were assessed by dynamic light scattering and scanning electron microscopy. The uptake of Ac-SDKP by RAW 264.7 macrophages and human and murine primary cardiac fibroblasts was confirmed by fluorescence microscopy and flow cytometry. Spectrum computerized tomography and competitive enzyme-linked immunoassays were performed to measure the ex vivo cardiac biodistribution of Ac-SDKP. The biological effects of this novel synthetic compound were examined in cultured macrophages and cardiac fibroblasts and in a murine model of acute myocardial infarction induced by permanent coronary artery ligation. A liposome formulation resulted in the greater uptake of Ac-SDKP than the naked peptide by cultured RAW 264.7 macrophages and cardiac fibroblasts. Liposome-delivered Ac-SDKP decreased fibroinflammatory genes in cultured cardiac fibroblasts co-treated with TGF-β1 and macrophages stimulated with LPS. Serial tissue and serum immunoassays showed the high bioavailability of Ac-SDKP in mouse myocardium and in circulation. Liposome-delivered Ac-SDKP improved cardiac function and reduced myocardial fibroinflammatory responses in mice with acute myocardial infarction. Encapsulation of Ac-SDKP in a cell membrane-like phospholipid bilayer enhances its plasma and tissue bioavailability and offers cardioprotection against ischemic myocardial injury. Future clinical trials can use this novel approach to test small protective endogenous peptides in myocardial remodeling.